759 related articles for article (PubMed ID: 17157792)
21. Supervised risk predictor of breast cancer based on intrinsic subtypes.
Parker JS; Mullins M; Cheang MC; Leung S; Voduc D; Vickery T; Davies S; Fauron C; He X; Hu Z; Quackenbush JF; Stijleman IJ; Palazzo J; Marron JS; Nobel AB; Mardis E; Nielsen TO; Ellis MJ; Perou CM; Bernard PS
J Clin Oncol; 2009 Mar; 27(8):1160-7. PubMed ID: 19204204
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
Hennessy BT; Gonzalez-Angulo AM; Stemke-Hale K; Gilcrease MZ; Krishnamurthy S; Lee JS; Fridlyand J; Sahin A; Agarwal R; Joy C; Liu W; Stivers D; Baggerly K; Carey M; Lluch A; Monteagudo C; He X; Weigman V; Fan C; Palazzo J; Hortobagyi GN; Nolden LK; Wang NJ; Valero V; Gray JW; Perou CM; Mills GB
Cancer Res; 2009 May; 69(10):4116-24. PubMed ID: 19435916
[TBL] [Abstract][Full Text] [Related]
23. Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis.
Nagalla S; Chou JW; Willingham MC; Ruiz J; Vaughn JP; Dubey P; Lash TL; Hamilton-Dutoit SJ; Bergh J; Sotiriou C; Black MA; Miller LD
Genome Biol; 2013 Apr; 14(4):R34. PubMed ID: 23618380
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.
Eirew P; Steif A; Khattra J; Ha G; Yap D; Farahani H; Gelmon K; Chia S; Mar C; Wan A; Laks E; Biele J; Shumansky K; Rosner J; McPherson A; Nielsen C; Roth AJ; Lefebvre C; Bashashati A; de Souza C; Siu C; Aniba R; Brimhall J; Oloumi A; Osako T; Bruna A; Sandoval JL; Algara T; Greenwood W; Leung K; Cheng H; Xue H; Wang Y; Lin D; Mungall AJ; Moore R; Zhao Y; Lorette J; Nguyen L; Huntsman D; Eaves CJ; Hansen C; Marra MA; Caldas C; Shah SP; Aparicio S
Nature; 2015 Feb; 518(7539):422-6. PubMed ID: 25470049
[TBL] [Abstract][Full Text] [Related]
25. Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis.
Clarke C; Madden SF; Doolan P; Aherne ST; Joyce H; O'Driscoll L; Gallagher WM; Hennessy BT; Moriarty M; Crown J; Kennedy S; Clynes M
Carcinogenesis; 2013 Oct; 34(10):2300-8. PubMed ID: 23740839
[TBL] [Abstract][Full Text] [Related]
26. Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications.
Muranen TA; Greco D; Fagerholm R; Kilpivaara O; Kämpjärvi K; Aittomäki K; Blomqvist C; Heikkilä P; Borg A; Nevanlinna H
Breast Cancer Res; 2011 Sep; 13(5):R90. PubMed ID: 21542898
[TBL] [Abstract][Full Text] [Related]
27. A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers.
Yu K; Ganesan K; Tan LK; Laban M; Wu J; Zhao XD; Li H; Leung CH; Zhu Y; Wei CL; Hooi SC; Miller L; Tan P
PLoS Genet; 2008 Jul; 4(7):e1000129. PubMed ID: 18636107
[TBL] [Abstract][Full Text] [Related]
28. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response.
Jézéquel P; Loussouarn D; Guérin-Charbonnel C; Campion L; Vanier A; Gouraud W; Lasla H; Guette C; Valo I; Verrièle V; Campone M
Breast Cancer Res; 2015 Mar; 17():43. PubMed ID: 25887482
[TBL] [Abstract][Full Text] [Related]
29. Genome-driven integrated classification of breast cancer validated in over 7,500 samples.
Ali HR; Rueda OM; Chin SF; Curtis C; Dunning MJ; Aparicio SA; Caldas C
Genome Biol; 2014 Aug; 15(8):431. PubMed ID: 25164602
[TBL] [Abstract][Full Text] [Related]
30. Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.
Melchor L; Molyneux G; Mackay A; Magnay FA; Atienza M; Kendrick H; Nava-Rodrigues D; López-García MÁ; Milanezi F; Greenow K; Robertson D; Palacios J; Reis-Filho JS; Smalley MJ
J Pathol; 2014 Jun; 233(2):124-37. PubMed ID: 24615332
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
Itoh M; Iwamoto T; Matsuoka J; Nogami T; Motoki T; Shien T; Taira N; Niikura N; Hayashi N; Ohtani S; Higaki K; Fujiwara T; Doihara H; Symmans WF; Pusztai L
Breast Cancer Res Treat; 2014 Jan; 143(2):403-9. PubMed ID: 24337596
[TBL] [Abstract][Full Text] [Related]
32. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.
Botling J; Edlund K; Lohr M; Hellwig B; Holmberg L; Lambe M; Berglund A; Ekman S; Bergqvist M; Pontén F; König A; Fernandes O; Karlsson M; Helenius G; Karlsson C; Rahnenführer J; Hengstler JG; Micke P
Clin Cancer Res; 2013 Jan; 19(1):194-204. PubMed ID: 23032747
[TBL] [Abstract][Full Text] [Related]
33. GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer.
Miyake T; Nakayama T; Naoi Y; Yamamoto N; Otani Y; Kim SJ; Shimazu K; Shimomura A; Maruyama N; Tamaki Y; Noguchi S
Cancer Sci; 2012 May; 103(5):913-20. PubMed ID: 22320227
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.
Tabchy A; Valero V; Vidaurre T; Lluch A; Gomez H; Martin M; Qi Y; Barajas-Figueroa LJ; Souchon E; Coutant C; Doimi FD; Ibrahim NK; Gong Y; Hortobagyi GN; Hess KR; Symmans WF; Pusztai L
Clin Cancer Res; 2010 Nov; 16(21):5351-61. PubMed ID: 20829329
[TBL] [Abstract][Full Text] [Related]
35. Genomic index of sensitivity to endocrine therapy for breast cancer.
Symmans WF; Hatzis C; Sotiriou C; Andre F; Peintinger F; Regitnig P; Daxenbichler G; Desmedt C; Domont J; Marth C; Delaloge S; Bauernhofer T; Valero V; Booser DJ; Hortobagyi GN; Pusztai L
J Clin Oncol; 2010 Sep; 28(27):4111-9. PubMed ID: 20697068
[TBL] [Abstract][Full Text] [Related]
36. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.
Holm K; Hegardt C; Staaf J; Vallon-Christersson J; Jönsson G; Olsson H; Borg A; Ringnér M
Breast Cancer Res; 2010; 12(3):R36. PubMed ID: 20565864
[TBL] [Abstract][Full Text] [Related]
37. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
Weigelt B; Baehner FL; Reis-Filho JS
J Pathol; 2010 Jan; 220(2):263-80. PubMed ID: 19927298
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
Wirapati P; Sotiriou C; Kunkel S; Farmer P; Pradervand S; Haibe-Kains B; Desmedt C; Ignatiadis M; Sengstag T; Schütz F; Goldstein DR; Piccart M; Delorenzi M
Breast Cancer Res; 2008; 10(4):R65. PubMed ID: 18662380
[TBL] [Abstract][Full Text] [Related]
39. Predicting features of breast cancer with gene expression patterns.
Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
[TBL] [Abstract][Full Text] [Related]
40. Lung metastasis genes couple breast tumor size and metastatic spread.
Minn AJ; Gupta GP; Padua D; Bos P; Nguyen DX; Nuyten D; Kreike B; Zhang Y; Wang Y; Ishwaran H; Foekens JA; van de Vijver M; Massagué J
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6740-5. PubMed ID: 17420468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
